LC-MS/MS analysis of 11-nor-9-carboxy-hexahydrocannabinol (HHC-COOH) and 11-hydroxy-hexahydrocannabinol (HHC-OH) for verification of hexahydrocannabinol (HHC) intake
Natural and semi-synthetic cannabinoid analogs are getting increasing media attention for their recreative use as an alternative to traditional cannabis, in Sweden as well as internationally. To investigate an increasing number of urine samples incoming to our clinical laboratory that were screening...
Uloženo v:
| Vydáno v: | Scandinavian journal of clinical and laboratory investigation Ročník 84; číslo 2; s. 109 - 114 |
|---|---|
| Hlavní autoři: | , |
| Médium: | Journal Article |
| Jazyk: | angličtina |
| Vydáno: |
England
01.04.2024
|
| Témata: | |
| ISSN: | 0036-5513, 1502-7686, 1502-7686 |
| On-line přístup: | Získat plný text |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
|
| Abstract | Natural and semi-synthetic cannabinoid analogs are getting increasing media attention for their recreative use as an alternative to traditional cannabis, in Sweden as well as internationally. To investigate an increasing number of urine samples incoming to our clinical laboratory that were screening positive, using a CEDIA THC-COOH immunoassay from ThermoFisher Scientific, but then testing negative using GC-MS based verification analysis, we developed an LC-MS/MS-method for verification of hexahydrocannabinol (HHC) and Δ8-tetrahydrocannabinol. Assessment of HHC intake was based on identification of the following four metabolites: 11-nor-9(R)-carboxy-hexahydrocannabinol (R-HHC-COOH), 11-nor-9(S)-carboxy-hexahydrocannabinol (S-HHC-COOH), 11-hydroxy-9(R)-hexahydrocannabinol (R-HHC-OH) and 11-hydroxy-9(S)-hexahydrocannabinol (S-HHC-OH). Out of 46 urine samples analysed in this study, 44 showed presence of HHC-metabolites, which indicate HHC as the main explanation for an increased number of negative verifications for THC-COOH. In these samples, the HHC-OH metabolites occurred at a higher concentration than R-HHC-COOH while S-HHC-COOH was only detected in few samples at low concentrations. R-HHC-COOH and S-HHC-COOH can easily be added to a pre-existing verification method for THC-COOH, and still show acceptable results, while HHC-OH requires an enzyme capable of hydrolysing the ether glucuronide bond. |
|---|---|
| AbstractList | Natural and semi-synthetic cannabinoid analogs are getting increasing media attention for their recreative use as an alternative to traditional cannabis, in Sweden as well as internationally. To investigate an increasing number of urine samples incoming to our clinical laboratory that were screening positive, using a CEDIA THC-COOH immunoassay from ThermoFisher Scientific, but then testing negative using GC-MS based verification analysis, we developed an LC-MS/MS-method for verification of hexahydrocannabinol (HHC) and Δ8-tetrahydrocannabinol. Assessment of HHC intake was based on identification of the following four metabolites: 11-nor-9(R)-carboxy-hexahydrocannabinol (R-HHC-COOH), 11-nor-9(S)-carboxy-hexahydrocannabinol (S-HHC-COOH), 11-hydroxy-9(R)-hexahydrocannabinol (R-HHC-OH) and 11-hydroxy-9(S)-hexahydrocannabinol (S-HHC-OH). Out of 46 urine samples analysed in this study, 44 showed presence of HHC-metabolites, which indicate HHC as the main explanation for an increased number of negative verifications for THC-COOH. In these samples, the HHC-OH metabolites occurred at a higher concentration than R-HHC-COOH while S-HHC-COOH was only detected in few samples at low concentrations. R-HHC-COOH and S-HHC-COOH can easily be added to a pre-existing verification method for THC-COOH, and still show acceptable results, while HHC-OH requires an enzyme capable of hydrolysing the ether glucuronide bond. Natural and semi-synthetic cannabinoid analogs are getting increasing media attention for their recreative use as an alternative to traditional cannabis, in Sweden as well as internationally. To investigate an increasing number of urine samples incoming to our clinical laboratory that were screening positive, using a CEDIA THC-COOH immunoassay from ThermoFisher Scientific, but then testing negative using GC-MS based verification analysis, we developed an LC-MS/MS-method for verification of hexahydrocannabinol (HHC) and Δ8-tetrahydrocannabinol. Assessment of HHC intake was based on identification of the following four metabolites: 11-nor-9(R)-carboxy-hexahydrocannabinol (R-HHC-COOH), 11-nor-9(S)-carboxy-hexahydrocannabinol (S-HHC-COOH), 11-hydroxy-9(R)-hexahydrocannabinol (R-HHC-OH) and 11-hydroxy-9(S)-hexahydrocannabinol (S-HHC-OH). Out of 46 urine samples analysed in this study, 44 showed presence of HHC-metabolites, which indicate HHC as the main explanation for an increased number of negative verifications for THC-COOH. In these samples, the HHC-OH metabolites occurred at a higher concentration than R-HHC-COOH while S-HHC-COOH was only detected in few samples at low concentrations. R-HHC-COOH and S-HHC-COOH can easily be added to a pre-existing verification method for THC-COOH, and still show acceptable results, while HHC-OH requires an enzyme capable of hydrolysing the ether glucuronide bond.Natural and semi-synthetic cannabinoid analogs are getting increasing media attention for their recreative use as an alternative to traditional cannabis, in Sweden as well as internationally. To investigate an increasing number of urine samples incoming to our clinical laboratory that were screening positive, using a CEDIA THC-COOH immunoassay from ThermoFisher Scientific, but then testing negative using GC-MS based verification analysis, we developed an LC-MS/MS-method for verification of hexahydrocannabinol (HHC) and Δ8-tetrahydrocannabinol. Assessment of HHC intake was based on identification of the following four metabolites: 11-nor-9(R)-carboxy-hexahydrocannabinol (R-HHC-COOH), 11-nor-9(S)-carboxy-hexahydrocannabinol (S-HHC-COOH), 11-hydroxy-9(R)-hexahydrocannabinol (R-HHC-OH) and 11-hydroxy-9(S)-hexahydrocannabinol (S-HHC-OH). Out of 46 urine samples analysed in this study, 44 showed presence of HHC-metabolites, which indicate HHC as the main explanation for an increased number of negative verifications for THC-COOH. In these samples, the HHC-OH metabolites occurred at a higher concentration than R-HHC-COOH while S-HHC-COOH was only detected in few samples at low concentrations. R-HHC-COOH and S-HHC-COOH can easily be added to a pre-existing verification method for THC-COOH, and still show acceptable results, while HHC-OH requires an enzyme capable of hydrolysing the ether glucuronide bond. |
| Author | Pettersson-Pablo, Paul Oxelbark, Joakim |
| Author_xml | – sequence: 1 givenname: Paul orcidid: 0000-0001-8458-6448 surname: Pettersson-Pablo fullname: Pettersson-Pablo, Paul organization: Department of Laboratory Medicine, Clinical Chemistry, Örebro University Hospital, Örebro, Sweden, School of Medicine, Faculty of Medicine and Health, Örebro University, Örebro, Sweden – sequence: 2 givenname: Joakim orcidid: 0000-0002-8101-5137 surname: Oxelbark fullname: Oxelbark, Joakim organization: Department of Laboratory Medicine, Clinical Chemistry, Örebro University Hospital, Örebro, Sweden, School of Medicine, Faculty of Medicine and Health, Örebro University, Örebro, Sweden |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/38529884$$D View this record in MEDLINE/PubMed https://urn.kb.se/resolve?urn=urn:nbn:se:oru:diva-112636$$DView record from Swedish Publication Index (Örebro universitet) |
| BookMark | eNp9kc9uEzEQhy1URNPCI4D22B6c-s_ascWp2gJBSpVDgas16_VSw8YO9i40D8R7stskHJDoYTQa6ftmpPmdoZMQg0PoNSVzShS5IoRLISifM8LKOeOcE8afoRkVhOGFVPIEzSYGT9ApOsv5GxlnrsoX6JQrwbRS5Qz9XlX49u7q9q6AAN0u-1zEtqAUh5iwxhZSHR92-N49wP2uSdFCCFD7ELviYrmscLVeLy9Ht5mcR-IpemLbmIqfLvnWW-h9DNO9_wmXhQ89fHcv0fMWuuxeHfo5-vz-3adqiVfrDx-r6xW2XJc9ZlwtBHOW1lpD6Zi2lqlW8LYuqWxK7RonnGpqKoAJrhoqqRRUWtDjo1oC_Bzh_d78y22H2myT30DamQje3Pgv1yamr2MNhlImuRz5iz2_TfHH4HJvNj5b13UQXByy4aTUC8aJ0iP65oAO9cY1f1cfoxiBt3vApphzcq2xvn_8UJ_Ad4YSMwVvjsGbKXhzCH60xT_28cDT3h-DCK6z |
| CitedBy_id | crossref_primary_10_1002_dta_3871 crossref_primary_10_1093_jat_bkae091 crossref_primary_10_1016_j_cca_2025_120480 |
| Cites_doi | 10.1002/dta.1998 10.1093/jat/20.5.291 10.1002/dta.3519 10.3390/ph17020249 10.1002/dta.3190 10.1016/j.psc.2023.03.008 10.1002/dta.2230 10.1016/j.drugpo.2019.03.006 10.1093/jat/bkad059 10.1177/14690667231200139 10.1093/jat/bku075 10.2165/00003088-200342040-00003 10.1093/jat/19.5.292 |
| ContentType | Journal Article |
| DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 7X8 AABEP ADTPV AOWAS D8T D91 ZZAVC |
| DOI | 10.1080/00365513.2024.2333023 |
| DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic SWEPUB Örebro universitet full text SwePub SwePub Articles SWEPUB Freely available online SWEPUB Örebro universitet SwePub Articles full text |
| DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
| DatabaseTitleList | MEDLINE MEDLINE - Academic |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: 7X8 name: MEDLINE - Academic url: https://search.proquest.com/medline sourceTypes: Aggregation Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine |
| EISSN | 1502-7686 |
| EndPage | 114 |
| ExternalDocumentID | oai_DiVA_org_oru_112636 38529884 10_1080_00365513_2024_2333023 |
| Genre | Journal Article |
| GroupedDBID | --- -~X .55 .GJ 00X 03L 0R~ 123 34G 36B 39C 3O- 4.4 53G 5RE 5VS AAGDL AAJKZ AALIY AALUX AAMIU AAORF AAPUL AAPXX AAQQT AAQRR AAWTL AAYXX ABBKH ABDBF ABEIZ ABJNI ABLIJ ABLJU ABLKL ABOCM ABUPF ABWCV ABWVI ABXYU ABZEW ACENM ACGEJ ACGFS ACIEZ ACKZS ACOPL ACUHS ACYZI ADCVX ADFOM ADFZZ ADRBQ ADXPE AECIN AEIIZ AENEX AEOZL AFFNX AFKVX AFLEI AFRVT AGDLA AGFJD AGRBW AGYJP AIJEM AIRBT AJVHN AJWEG AKBVH ALMA_UNASSIGNED_HOLDINGS ALQZU ALYBC AMDAE AWYRJ BABNJ BLEHA BOHLJ BRMBE CAG CCCUG CITATION COF CS3 CYYVM CZDIS DKSSO DRXRE DU5 DWTOO EAP EAS EBB EBC EBD EBS EBX EHN EJD EMB EMK EMOBN EPL EPT ESX F5P H13 HZ~ JENTW KRBQP KSSTO KWAYT KYCEM L7B LJTGL M44 M4Z NUSFT O9- OVD P2P QQXMO Q~Q RNANH RVRKI SV3 TASJS TBQAZ TDBHL TEORI TERGH TFDNU TFL TFW TUROJ TUS UEQFS UHWXJ V1S WH7 X7M ZGI ZXP ~1N ADYSH CGR CUY CVF ECM EIF NPM 7X8 AABEP ADTPV AOWAS AQTUD D8T D91 ZZAVC |
| ID | FETCH-LOGICAL-c394t-238752ec1b99a4e29cc28f53fb416d49ede5e8db15a2538d1616516ca9036f0a3 |
| ISICitedReferencesCount | 5 |
| ISICitedReferencesURI | http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=001191006300001&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| ISSN | 0036-5513 1502-7686 |
| IngestDate | Tue Nov 04 17:23:50 EST 2025 Thu Oct 02 12:29:31 EDT 2025 Thu Apr 03 07:06:55 EDT 2025 Sat Nov 29 02:41:45 EST 2025 Tue Nov 18 19:36:57 EST 2025 |
| IsDoiOpenAccess | true |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 2 |
| Keywords | Cannabis narcotics urine cannabinoids liquid Chromatography-Mass spectrometry hydrolysis immunoassay |
| Language | English |
| LinkModel | OpenURL |
| MergedId | FETCHMERGED-LOGICAL-c394t-238752ec1b99a4e29cc28f53fb416d49ede5e8db15a2538d1616516ca9036f0a3 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
| ORCID | 0000-0002-8101-5137 0000-0001-8458-6448 |
| OpenAccessLink | https://urn.kb.se/resolve?urn=urn:nbn:se:oru:diva-112636 |
| PMID | 38529884 |
| PQID | 3049723089 |
| PQPubID | 23479 |
| PageCount | 6 |
| ParticipantIDs | swepub_primary_oai_DiVA_org_oru_112636 proquest_miscellaneous_3049723089 pubmed_primary_38529884 crossref_citationtrail_10_1080_00365513_2024_2333023 crossref_primary_10_1080_00365513_2024_2333023 |
| PublicationCentury | 2000 |
| PublicationDate | 2024-04-01 |
| PublicationDateYYYYMMDD | 2024-04-01 |
| PublicationDate_xml | – month: 04 year: 2024 text: 2024-04-01 day: 01 |
| PublicationDecade | 2020 |
| PublicationPlace | England |
| PublicationPlace_xml | – name: England |
| PublicationTitle | Scandinavian journal of clinical and laboratory investigation |
| PublicationTitleAlternate | Scand J Clin Lab Invest |
| PublicationYear | 2024 |
| References | e_1_3_2_9_1 e_1_3_2_17_1 e_1_3_2_8_1 e_1_3_2_18_1 e_1_3_2_7_1 e_1_3_2_19_1 e_1_3_2_2_1 e_1_3_2_20_1 e_1_3_2_10_1 e_1_3_2_11_1 e_1_3_2_6_1 e_1_3_2_12_1 e_1_3_2_5_1 e_1_3_2_13_1 e_1_3_2_4_1 e_1_3_2_15_1 Helander A (e_1_3_2_3_1) 2021; 118 Albertson TE (e_1_3_2_14_1) 2016; 441 Ferretti ML (e_1_3_2_16_1) |
| References_xml | – ident: e_1_3_2_8_1 – ident: e_1_3_2_19_1 doi: 10.1002/dta.1998 – ident: e_1_3_2_11_1 doi: 10.1093/jat/20.5.291 – ident: e_1_3_2_5_1 doi: 10.1002/dta.3519 – ident: e_1_3_2_10_1 doi: 10.3390/ph17020249 – ident: e_1_3_2_12_1 doi: 10.1002/dta.3190 – ident: e_1_3_2_2_1 doi: 10.1016/j.psc.2023.03.008 – ident: e_1_3_2_20_1 doi: 10.1002/dta.2230 – ident: e_1_3_2_6_1 – ident: e_1_3_2_15_1 doi: 10.1016/j.drugpo.2019.03.006 – ident: e_1_3_2_16_1 article-title: A survey study of individuals using hexahydrocannabinol cannabis products: use patterns and perceived effects publication-title: Cannabis Cannabinoid Res – ident: e_1_3_2_17_1 doi: 10.1093/jat/bkad059 – ident: e_1_3_2_9_1 doi: 10.1177/14690667231200139 – ident: e_1_3_2_7_1 doi: 10.1093/jat/bku075 – ident: e_1_3_2_13_1 – ident: e_1_3_2_4_1 doi: 10.2165/00003088-200342040-00003 – ident: e_1_3_2_18_1 doi: 10.1093/jat/19.5.292 – volume: 441 start-page: 18 year: 2016 ident: e_1_3_2_14_1 article-title: The changing drug culture: emerging drugs of abuse and legal highs publication-title: FP Essent – volume: 118 start-page: 21056 year: 2021 ident: e_1_3_2_3_1 article-title: [Drug use and drug trends in Sweden 2010-2020 - results from urine drug testing in the workplace] publication-title: Lakartidningen |
| SSID | ssj0003384 |
| Score | 2.391516 |
| Snippet | Natural and semi-synthetic cannabinoid analogs are getting increasing media attention for their recreative use as an alternative to traditional cannabis, in... |
| SourceID | swepub proquest pubmed crossref |
| SourceType | Open Access Repository Aggregation Database Index Database Enrichment Source |
| StartPage | 109 |
| SubjectTerms | cannabinoids Cannabis Dronabinol - analogs & derivatives Dronabinol - urine Gas Chromatography-Mass Spectrometry - methods Humans hydrolysis immunoassay Liquid Chromatography-Mass Spectrometry narcotics Substance Abuse Detection - methods Tandem Mass Spectrometry - methods urine |
| Title | LC-MS/MS analysis of 11-nor-9-carboxy-hexahydrocannabinol (HHC-COOH) and 11-hydroxy-hexahydrocannabinol (HHC-OH) for verification of hexahydrocannabinol (HHC) intake |
| URI | https://www.ncbi.nlm.nih.gov/pubmed/38529884 https://www.proquest.com/docview/3049723089 https://urn.kb.se/resolve?urn=urn:nbn:se:oru:diva-112636 |
| Volume | 84 |
| WOSCitedRecordID | wos001191006300001&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| journalDatabaseRights | – providerCode: PRVAWR databaseName: Taylor & Francis Journals Complete customDbUrl: eissn: 1502-7686 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0003384 issn: 0036-5513 databaseCode: TFW dateStart: 19490101 isFulltext: true titleUrlDefault: https://www.tandfonline.com providerName: Taylor & Francis |
| link | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1fb9MwELe6gaa9IP6vA6YgIcQeXBo7qe3HqTBVaF0rtUDfIsdxWEWXVF1bdR-IT8QX4pw4acroGA88NKoSn1359-v5Lr47I_TG82kYS8mw5jHFng8-K3ebIeah9IBAktEoSxQ-Y-fnfDQS_VrtZ5ELs5ywJOGrlZj-V6jhHoBtUmf_Ae6yU7gB3wF0uALscL0T8Gdt3B2AOHjoslJxxHVxks6wwErOwnR1jS_0Sl5cR7CAySSR4CCnE2Nudjpt3O71OuZ1gXmpDnJZq9sl8vYmZBHmy0QfVSzRbUJGYpzM5feNaKSByhJt5HJstwisuVymcJofZalr4gPG60Ih64iCfpakBBOd4L4M892lagxkb6UnoY0S_5SCEX1ZfftBqkEz2mpsUOngM7WqKj0_dc5Sl1T0s5vVYri5bhSBlrRlDrxpmJEahFJzolK1PSA9vcx4Q7lPBLfjbBbsLh7toHuE-cKo2uHp19I8oJR7RSqZKfL-pzH30V7Ry6a9dMMJ-q3CbWYVDR-iB9adcU5yGj5CNZ08RntdG7DxBP3I2Pi-O3AKLjpp7NyFi867gonHIBs5t_Mwb23aAgedKgfNeNsEjp2cf0_R59OPw3YH25NBsKLCm2OwM5lPtHJDIaSniVCK8NincQj-ReQJHWlf8yh0fUlgRY_ArWn5bktJAbMdNyV9hnaTNNEHyPG9SEmmGFjanicUC1XoutolRDFNYu3XkVfMf6Bs2XxzesskcNfVdTMEA4NgYBGso0YpNs3rxvxN4HUBbgAa3mzbyUSni6vAbIQzQptc1NHzHPWyy4IldfQ2p0H5xJSN_zD-chKks2_wWQQmV5C2Drd28QLtr_9gL9HufLbQr9B9tZyPr2ZHaIeN-FHG5F__s9Pr |
| linkProvider | Taylor & Francis |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=LC-MS%2FMS+analysis+of+11-nor-9-carboxy-hexahydrocannabinol+%28HHC-COOH%29+and+11-hydroxy-hexahydrocannabinol+%28HHC-OH%29+for+verification+of+hexahydrocannabinol+%28HHC%29+intake&rft.jtitle=Scandinavian+journal+of+clinical+and+laboratory+investigation&rft.au=Pettersson-Pablo%2C+Paul&rft.au=Oxelbark%2C+Joakim&rft.date=2024-04-01&rft.eissn=1502-7686&rft.volume=84&rft.issue=2&rft.spage=109&rft_id=info:doi/10.1080%2F00365513.2024.2333023&rft_id=info%3Apmid%2F38529884&rft.externalDocID=38529884 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0036-5513&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0036-5513&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0036-5513&client=summon |